Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. Brief Instruction 01 Safety of TMS in children02 TMS treatment of autism spectrum disorder03 TMS treatment of tourette syndrome04 TMS treatment of attention-deficit/hyperactivity disorder05 TMS treatment of treatment resistant disorder06 TMS treatment of generalized anxiety disorder 01 Safety of TMS in children IF=6.9 | Safty of noninvasive brain stimulation in... Read more
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. Lack of motivation is one of the typical features in major depressive disorder (MDD), which is manifested by reduced willingness to make efforts. The dorsolateral prefrontal cortex (DLPFC) plays a key role in goal-directed behavior and is therefore a potential target for regulating effort motivation. To explore... Read more
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. Theta burst transcranial magnetic stimulation Repetitive transcranial magnetic stimulation (rTMS) can induce lasting changes in brain activity and cortical excitability, and it has been widely used in the treatment of psychiatric and neurological diseases. With the continuous development of TMS technology, researchers have developed more treatment modes. Theta... Read more
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. Generalized anxiety disorder (GAD) is one of the most common disorders affecting adolescents and young adults, with prevalence rates rising significantly over the past decade. Although psychotherapy and pharmacotherapy are often effective, more than 30% of patients remain clinically unresponsive to these interventions. Additionally, patients and caregivers are... Read more
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd Professor Yan Min's team from the Department of Anesthesiology, the Second Affiliated Hospital of Zhejiang University School of Medicine, together with Associate Professor Che Xianwei's team from Hangzhou Normal University, have published their latest research results in “PAIN”, a leading journal in the field of pain. This study investigates... Read more
Clinical Support Department of Shenzhen Yingchi Technology Co.,Ltd. Repetitive transcranial magnetic stimulation (rTMS) was approved by the U.S. Food and Drug Administration (FDA) in 2008 for the treatment of major depression that is refractory to multiple medications. The initial treatment time of rTMS protocol is about 45 minutes, once a day for 20-30 days. This treatment... Read more
